These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34000147)

  • 1. Kratom: An Emerging Issue and Need for Regulations in the United States.
    Shah K; Tankersley W; Mekala H
    Prim Care Companion CNS Disord; 2021 Feb; 23(1):. PubMed ID: 34000147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the Pharmacology and Legal Status of Kratom.
    Prozialeck WC
    J Am Osteopath Assoc; 2016 Dec; 116(12):802-809. PubMed ID: 27893147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kratom: A growing substance of abuse in the United States.
    Demick DS; Lee TT; Summers AT; El-Mallakh RS
    Ann Clin Psychiatry; 2020 Nov; 32(4):275-280. PubMed ID: 32722734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kratom: The safe legal high?
    Coonan E; Tatum W
    Epilepsy Behav; 2021 Apr; 117():107882. PubMed ID: 33690067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Scheduling of Kratom and Selective Use of Data.
    Griffin OH; Webb ME
    J Psychoactive Drugs; 2018; 50(2):114-120. PubMed ID: 28937941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.
    Henningfield JE; Fant RV; Wang DW
    Psychopharmacology (Berl); 2018 Feb; 235(2):573-589. PubMed ID: 29273821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic.
    Garcia-Romeu A; Cox DJ; Smith KE; Dunn KE; Griffiths RR
    Drug Alcohol Depend; 2020 Mar; 208():107849. PubMed ID: 32029298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa).
    Hartley C; Bulloch M; Penzak SR
    J Clin Pharmacol; 2022 May; 62(5):577-593. PubMed ID: 34775626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic and clinical assessment of kratom: An update.
    White CM
    Am J Health Syst Pharm; 2019 Nov; 76(23):1915-1925. PubMed ID: 31626272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of death associated with kratom use compared to opioids.
    Henningfield JE; Grundmann O; Babin JK; Fant RV; Wang DW; Cone EJ
    Prev Med; 2019 Nov; 128():105851. PubMed ID: 31647958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015.
    Anwar M; Law R; Schier J
    MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(29):748-9. PubMed ID: 27466822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kratom Use Among U.S. Adolescents: Analyses of the 2019 National Survey on Drug Use and Health.
    Sharma V; Cottler LB; Bares CB; Lopez-Quintero C
    J Adolesc Health; 2022 Apr; 70(4):677-681. PubMed ID: 34836801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kratom (Mitragyna speciosa): worldwide issues.
    Ramanathan S; McCurdy CR
    Curr Opin Psychiatry; 2020 Jul; 33(4):312-318. PubMed ID: 32452943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebral hemorrhage after kratom ingestion.
    Regan GA; Papadakos PJ
    JAAPA; 2021 Apr; 34(4):33-36. PubMed ID: 33735138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute liver injury following short-term use of the herbal supplement kratom.
    Umbehr G; Lukaszewicz M
    JAAPA; 2022 Feb; 35(2):39-41. PubMed ID: 35076438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic and clinical assessment of kratom.
    White CM
    Am J Health Syst Pharm; 2018 Mar; 75(5):261-267. PubMed ID: 29255059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.
    Prozialeck WC; Jivan JK; Andurkar SV
    J Am Osteopath Assoc; 2012 Dec; 112(12):792-9. PubMed ID: 23212430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
    Warner ML; Kaufman NC; Grundmann O
    Int J Legal Med; 2016 Jan; 130(1):127-38. PubMed ID: 26511390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management.
    Bowe A; Kerr PL
    J Psychoactive Drugs; 2020; 52(5):447-452. PubMed ID: 32546067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
    Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
    J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.